Project description:Parabronema skrjabini is an widespread but neglected blood-feeding nematode. The P.skrjabini can ,as a pathogen ,causes the large ruminants clinical and pathological effects, with even severe infections being fatal, which is of a major veterinary importance in many developing countries. However, there is little information that controls the developmental changes of the parasite survived and developed in insect and ruminant hosts. Here we have collected P.sktjabini of four specific developmental stages and allows for complete understanding the key characteristics of development. We analyzed the transcriptomic changes accompanying the four specific developmental stages using RNA-seq and pinpointed the development-dependent function genes and biological processes.
Project description:Microbiome sequencing model is a Named Entity Recognition (NER) model that identifies and annotates microbiome nucleic acid sequencing method or platform in texts. This is the final model version used to annotate metagenomics publications in Europe PMC and enrich metagenomics studies in MGnify with sequencing metadata from literature. For more information, please refer to the following blogs: http://blog.europepmc.org/2020/11/europe-pmc-publications-metagenomics-annotations.html https://www.ebi.ac.uk/about/news/service-news/enriched-metadata-fields-mgnify-based-text-mining-associated-publications
Project description:Transcriptomic insight into differential gene expression patterns of the camel pathogenic nematode, Parabronema skrjabini, at specific developmental stages
Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).
Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).
Project description:An updated representation of S. meliloti metabolism that was manually-curated and encompasses information from 240 literature sources, which includes transposon-sequencing (Tn-seq) data and Phenotype MicroArray data for wild-type and mutant strains.